ATE119353T1 - Verminderung von post-prandial grossen neutralen aminosäureplasmakonzentrationen. - Google Patents

Verminderung von post-prandial grossen neutralen aminosäureplasmakonzentrationen.

Info

Publication number
ATE119353T1
ATE119353T1 AT90905824T AT90905824T ATE119353T1 AT E119353 T1 ATE119353 T1 AT E119353T1 AT 90905824 T AT90905824 T AT 90905824T AT 90905824 T AT90905824 T AT 90905824T AT E119353 T1 ATE119353 T1 AT E119353T1
Authority
AT
Austria
Prior art keywords
prandial
neutral amino
post
reduction
amino acid
Prior art date
Application number
AT90905824T
Other languages
English (en)
Inventor
Richard J Wurtman
Judith J Wurtman
Original Assignee
Interneuron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Interneuron Pharma filed Critical Interneuron Pharma
Application granted granted Critical
Publication of ATE119353T1 publication Critical patent/ATE119353T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pediatric Medicine (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Treating Waste Gases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT90905824T 1989-04-03 1990-04-02 Verminderung von post-prandial grossen neutralen aminosäureplasmakonzentrationen. ATE119353T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/332,871 US5206218A (en) 1989-04-03 1989-04-03 Reducing post-prandial fluctuations in plasma concentrations of large neutral amino acids (lnaa)

Publications (1)

Publication Number Publication Date
ATE119353T1 true ATE119353T1 (de) 1995-03-15

Family

ID=23300218

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90905824T ATE119353T1 (de) 1989-04-03 1990-04-02 Verminderung von post-prandial grossen neutralen aminosäureplasmakonzentrationen.

Country Status (9)

Country Link
US (1) US5206218A (de)
EP (1) EP0466769B1 (de)
JP (1) JPH04506597A (de)
AT (1) ATE119353T1 (de)
CA (1) CA2050585A1 (de)
DE (1) DE69017673T2 (de)
DK (1) DK0466769T3 (de)
ES (1) ES2072430T3 (de)
WO (1) WO1990011696A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5698525A (en) * 1989-04-03 1997-12-16 Interneuron Pharmaceuticals, Inc. Reducing post-prandial fluctuations in plasma concentrations of large neutral amino acids (LNAA)
US5432162A (en) * 1989-04-03 1995-07-11 Interneuron Pharmaceuticals, Inc. Reducing post-prandial fluctuations in plasma concentrations of large neutral amino acids (LNAA)
AU3929493A (en) * 1992-03-11 1993-10-05 Interneuron Pharmaceuticals, Inc. Reducing post-prandial fluctuations in plasma concentrations of large neutral amino acids (lnaa)
US5670539A (en) * 1993-07-21 1997-09-23 New York State Office Of Mental Health Treatment of movement disorders using large neutral amino acids
US5393784A (en) * 1993-07-21 1995-02-28 New York State Office Of Mental Health Treatment of tardive dyskinesia with leucine, isoleucine, valine or mixtures thereof
IE80469B1 (en) * 1993-09-13 1998-07-29 Elan Corp Plc Compositions for reducing fluctuations in plasma concentrations of large neutral amino acids and use thereof in therapy
US5480865A (en) * 1994-02-25 1996-01-02 Parkinson's Charitable Trust Nutritional composition
US5595772A (en) * 1995-06-07 1997-01-21 Massachusetts Institute Of Technology Composition and methods for losing weight
EP1073345B1 (de) * 1998-04-23 2007-10-24 Pro Dietic RDP (S.A.R.L.) Eiweisskomplement, dieselben enthaltende lebensmittelzubereitung, verfahren zu ihrer herstellung und anwendung derselben
FR2777751B1 (fr) * 1998-04-23 2001-11-02 Pro Dietic Rdp Complement proteique, composition alimentaire le contenant, leur procede de preparation et leur utilisation.
US20060257469A1 (en) * 2005-04-05 2006-11-16 Bulka Yochanan R Enhanced indoleamine and catecholamine bio-availability via catechin inhibition of L-Dopa decarboxylase

Also Published As

Publication number Publication date
ES2072430T3 (es) 1995-07-16
US5206218A (en) 1993-04-27
EP0466769B1 (de) 1995-03-08
JPH04506597A (ja) 1992-11-19
EP0466769A1 (de) 1992-01-22
DE69017673D1 (de) 1995-04-13
WO1990011696A1 (en) 1990-10-18
DK0466769T3 (da) 1995-03-27
CA2050585A1 (en) 1990-10-04
DE69017673T2 (de) 1995-07-06

Similar Documents

Publication Publication Date Title
ATE119353T1 (de) Verminderung von post-prandial grossen neutralen aminosäureplasmakonzentrationen.
ATE47005T1 (de) Enterales diaetisches produkt, mittel und verfahren zu dessen herstellung.
PT1133238E (pt) Processo de preapacao de uma composicao proteica e de uma formula infantil que a contem
BR9407047A (pt) Processo para separaçao de uma proteina de uma soluçao aquosa de proteinas
BE904225A (fr) Procede de fractionnement de proteines.
BR9907995A (pt) Métodos imunológicos para modular miostatina em sujeitos vertebrados
DE69027865D1 (de) ZUSAMMENSETZUNGEN enthaltend omega Conotoxin Peptide Derivate und deren Verwendung ZUR BEHANDLUNG VON ISCHÄMIE-ARTIGEN NEURONALEN SCHÄDIGUNGEN
IT1203873B (it) Composizioni farmaceutiche che lo surfattante polmonare naturale, contengono. metodo di preparazione e
ATE215320T1 (de) Nahrungszusammensetzungen in verschiedenen formen
ATE114156T1 (de) Herstellung von proteinen in aktiver form.
RU94046295A (ru) L-аспартил-d- альфа -аминоалканоил-(s)-n-d-алкилбензиламиды, используемые в качестве искусственных подслащивающих агентов, пищевой состав, способ подслащивания пищевого состава
DE69506882D1 (de) Wasserlösliche organische salze von kreatin
BR9808477B1 (pt) produtos com altos teores de beta-conglicinina e seus usos.
BG102279A (bg) Препарат за двуетапно прилагане
ATE192283T1 (de) Verfahren zur verarbeitung proteinhaltiger pflanzen
JO1677B1 (en) 3,3 'compounds - dithiobase (prepernic acid) and its organic salts
MXPA02010643A (es) Un metodo de tratamiento de proteinas de soya y un producto de proteina de soya producido mediante este metodo.
ATE74762T1 (de) Pharmazeutisches praeparat zur behandlung von stoerungen des fettstoffwechsels (hyperlipoproteinaemien).
DK0406216T3 (da) Protein-S-holdigt farmaceutisk præparat
DK0850044T3 (da) Fremgangsmåde til udvinding af aminosyrer af proteiner og anvendelse af disse aminosyreholdig produkter
KR890008166A (ko) 융합 단백질의 선택적 분해 방법
NO890932D0 (no) Modifiserte proteiner.
DK0538690T3 (da) Arylquinolyl-substituerede 1,4-dihydropyridin-dicarboxylsyrederivater, fremgangsmåde til deres fremstilling af deres anvendelse i lægemidler
BR9004693A (pt) Solucao aquosa,processo para aumentar a concentracao de proteina de uma proteina em uma solucao aquosa,e composicao farmaceutica
DE58907746D1 (de) Verfahren zur Bestimmung von Fructosamin.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee